Ann T.

机构：Université Paris Cité, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ORCID：0000-0002-9059-111X

发表论文 62 篇 · 总被引 1375 次 · h-index 17

代表论文

• Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study (2023 · The Lancet · 被引 166)
• Simvastatin and Rifaximin in Decompensated Cirrhosis (2025 · JAMA · 被引 41)
• Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis (2024 · Journal of Hepatology · 被引 30)
• Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis (2023 · Gut · 被引 30)
• IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B (2023 · Hepatology Communications · 被引 21)
• Shortening the albumin challenge from 48 to 24 hours may lead to overdiagnosis of hepatorenal syndrome-acute kidney injury and overtreatment with terlipressin (2024 · Journal of Hepatology · 被引 18)